Drug Search Results
More Filters [+]

Butoconazole

Alternative Names: butoconazole, femstat 3, femstat, gynazole-1, gynazole 1
Latest Update: 2022-08-10
Latest Update Note: Clinical Trial Update

Product Description

Butoconazole is used to treat yeast infections of the vagina. Butoconazole nitrate is an antifungal prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of vulvovaginal candidiasis, which is an infection of the female vulva and vagina. Vulvovaginal candidiasis is a type of mucocutaneous candidiasis. Butoconazole is a member of the class of imidazoles that is 1H-imidazole in which the hydrogen attached to the nitrogen is substituted by a 4-(4-chlorophenyl)-2-[(2,6-dichlorophenyl)sulfanyl]butyl group. (Sourced from: https://medlineplus.gov/druginfo/meds/a682012.html)

Mechanisms of Action: CYP51A1 Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Vaginal,Oral

FDA Designation: None *

Approval Status: Approved

Approved Countries: Bangladesh | Belgium | Brazil | Bulgaria | Canada | Chile | Colombia | Dominican Republic | Ecuador | Egypt | Hungary | India | Korea | Latvia | Luxembourg | Morocco | Netherlands | Pakistan | Peru | Poland | Romania | Russia | Serbia | Slovakia | Slovenia | Taiwan | United States

Approved Indications: None

Known Adverse Events: None

Company: Lumara Health
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Butoconazole

Countries in Clinic: China

Active Clinical Trial Count: 1

Highest Development Phases

Phase 2: Candidiasis, Vulvovaginal

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

CTR20132863

P2

Active, not recruiting

Candidiasis, Vulvovaginal

2016-04-11

Recent News Events

Date

Type

Title